PLEASANTON, CA, US, – NeoTract, Inc., today announced that the UK’s National Institute for Health and Care Excellence (NICE) has issued an Interventional Procedure Guidance (IPG) approving the UroLift prostatic urethral lift implant for use by UK doctors. The NICE guidance was made following consultations with independent clinical experts and a literature review.
NICE says: “The specialist advisers listed key efficacy outcomes as symptom improvement, improvement in quality of life, reducing or stopping medical therapy [drug therapy], … Continue reading NICE gives go ahead to NeoTract’s groundbreaking UroLift® Prostate Implant that can preserve sexual function while offering urinary symptom relief for millions of men affected by enlarged prostates